NOTE 12:-

SHAREHOLDERS' EQUITY

Authorized, issued and outstanding share capital in historical terms is as follows:

	Authorized		Issued and outstanding
	December 31		December 31,
	2019 and 2018		2019		2018
	Number of shares

Ordinary shares of par value NIS 3.0 each		10,000,000		4,380,268		2,028,552

Stock Option Plan:

The Company’s 2018 Share Incentive Plan (the "Plan") authorized the grant of options to purchase shares and restricted shares unites (“RSUs”) to officers, employees, directors and consultants of the Company and its Subsidiaries. Awards granted under the Plan to participants in various jurisdictions may be subject to specific terms and conditions for such grants as may be approved by the Company’s board from time to time.

Each option granted under the Plan is exercisable for a period of ten years from the date of the grant of the option or the expiration dates of the option plan. The options primarily vest gradually over four years of employment.

In July 2018 the Company granted options to acquire 60,857 Ordinary shares under the Plan. During 2019, 62,662 options were granted (including adjustment to options previously granted to reflect the dilutive effect of the rights offering) under the plan and no options were exercised. The total fair value of the options granted is recognized over four years vesting period.

As of December 31, 2019, options to purchase 123,519 ordinary shares were outstanding under the plan, exercisable at an average exercise price of $4.65 per share. The stock-based compensation expense related to employees' equity-based awards, recognized during 2019 and 2018 was $141 and $56, respectively.

A summary of employee option activity under the Plan as of December 31, 2019 and changes during the year ended December 31, 2019 are as follows:

	Number of options		Weighted-average exercise price		Weighted- average remaining contractual life (in months)		Aggregate intrinsic value (in thousands)

Outstanding at January 1, 2019		60,857		4.17		102		-
Granted		62,662		5.12		111		12

Outstanding at December 31, 2019		123,519		4.65		107		12

Exercisable at December 31, 2019		25,022		4.17		102		-

The weighted-average fair value of options granted during the years ended December 31, 2019 and 2018 were $5.12 and $4.17, respectively. No options were granted in 2017. The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the fourth quarter of fiscal 2019 and 2018 and the exercise price, multiplied by the number of in-the-money options). This amount changes, based on the fair market value of the Company's stock. As of December 31, 2019, there was approximately $205 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's stock option plans. This cost is expected to be recognized over a period of up to 3.7 years.